Literature DB >> 9445270

Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma.

E Crimi1, A Spanevello, M Neri, P W Ind, G A Rossi, V Brusasco.   

Abstract

In asthma, the acute increment of airway responsiveness caused by exposure to allergen is associated with influx of eosinophils into the airways. The relationship between chronic airway hyperresponsiveness and airway inflammation is unclear, as they do not change consistently following long-term anti-inflammatory treatments. We studied 71 patients with chronic asthma and allergic sensitization to perennial allergens. Airway responsiveness was determined by inhalation of methacholine, and airway inflammation was quantified by induced sputum (n = 28) or bronchoalveolar lavage (n = 43) and bronchial biopsy (n = 20). The relationships between airway responsiveness and the numbers of different inflammatory cells were assessed by multiple regression analysis. No significant correlations were found between the degree of airway responsiveness and the numbers of inflammatory cells in sputum or bronchoalveolar lavage or bronchial biopsy. By contrast, baseline lung function was inversely related to the numbers of eosinophils and directly related to the numbers of macrophages. The eosinophil cationic protein contents of either sputum or bronchoalveolar lavage were significantly correlated with the percentages of eosinophils but not with airway responsiveness. We suggest that other factors (e.g., airway wall remodeling or autonomic dysfunction) may be responsible for most of the interindividual variability of airway responsiveness in asthma.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9445270     DOI: 10.1164/ajrccm.157.1.9703002

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  86 in total

1.  Dissociation between exhaled nitric oxide and hyperresponsiveness in children with mild intermittent asthma.

Authors:  M Silvestri; D Spallarossa; E Battistini; V Brusasco; G A Rossi
Journal:  Thorax       Date:  2000-06       Impact factor: 9.139

Review 2.  Association of sputum parameters with clinical and functional measurements in asthma.

Authors:  E Rosi; G Scano
Journal:  Thorax       Date:  2000-03       Impact factor: 9.139

Review 3.  Airway hyperresponsiveness in asthma: not just a matter of airway inflammation.

Authors:  V Brusasco; E Crimi; R Pellegrino
Journal:  Thorax       Date:  1998-11       Impact factor: 9.139

Review 4.  How much asthma is really attributable to atopy?

Authors:  N Pearce; J Pekkanen; R Beasley
Journal:  Thorax       Date:  1999-03       Impact factor: 9.139

5.  Effect of methacholine challenge on cellular composition of sputum induction.

Authors:  A Spanevello; A M Vignola; A Bonanno; M Confalonieri; E Crimi; V Brusasco
Journal:  Thorax       Date:  1999-01       Impact factor: 9.139

6.  Relationships between airway hyperresponsiveness, inflammation, and calibre in asthma.

Authors:  Philip M Short; Samuel I W Lipworth; Brian J Lipworth
Journal:  Lung       Date:  2011-10-08       Impact factor: 2.584

7.  Diagnostic accuracy of exhaled nitric oxide in asthma: a meta-analysis of 4,691 participants.

Authors:  Zhenzhen Li; Wenzhe Qin; Lei Li; Qin Wu; Youjuan Wang
Journal:  Int J Clin Exp Med       Date:  2015-06-15

8.  Regulator of G-protein signaling-5 inhibits bronchial smooth muscle contraction in severe asthma.

Authors:  Zhao Yang; Nariman Balenga; Philip R Cooper; Gautam Damera; Richard Edwards; Christopher E Brightling; Reynold A Panettieri; Kirk M Druey
Journal:  Am J Respir Cell Mol Biol       Date:  2012-01-26       Impact factor: 6.914

9.  Role of prostaglandin D2 /CRTH2 pathway on asthma exacerbation induced by Aspergillus fumigatus.

Authors:  Haixia Liu; Mingrui Zheng; Jianou Qiao; Yajie Dang; Pengyu Zhang; Xianqiao Jin
Journal:  Immunology       Date:  2014-05       Impact factor: 7.397

Review 10.  Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma.

Authors:  S S An; T R Bai; J H T Bates; J L Black; R H Brown; V Brusasco; P Chitano; L Deng; M Dowell; D H Eidelman; B Fabry; N J Fairbank; L E Ford; J J Fredberg; W T Gerthoffer; S H Gilbert; R Gosens; S J Gunst; A J Halayko; R H Ingram; C G Irvin; A L James; L J Janssen; G G King; D A Knight; A M Lauzon; O J Lakser; M S Ludwig; K R Lutchen; G N Maksym; J G Martin; T Mauad; B E McParland; S M Mijailovich; H W Mitchell; R W Mitchell; W Mitzner; T M Murphy; P D Paré; R Pellegrino; M J Sanderson; R R Schellenberg; C Y Seow; P S P Silveira; P G Smith; J Solway; N L Stephens; P J Sterk; A G Stewart; D D Tang; R S Tepper; T Tran; L Wang
Journal:  Eur Respir J       Date:  2007-05       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.